Navigation Links
Novel gene predicts local recurrence in early onset breast cancer
Date:5/6/2009

HOUSTON - A newly discovered gene known as DEAR1 is mutated in breast cancer and is an independent predictor of local recurrence-free survival in early-onset breast cancer, a research team headed by scientists at The University of Texas M. D. Anderson Cancer Center reports in the journal PLoS Medicine.

"The correlation with local recurrence is significant because so many young women have recurrences in the breast, and cancers that do recur tend to be more aggressive," said senior author Ann McNeill Killary, Ph.D., professor in M. D. Anderson's Department of Genetics. "Young age has been considered a risk factor for local recurrence and metastasis. It is important to understand the genetic mechanisms operating in early-onset breast cancer and to determine whether there is a way to identify young women who might be at a higher risk of recurrence."

After Killary's laboratory research discovered DEAR1 (ductal epithelium-associated ring chromosome 1) and implicated it in breast cancer, the team examined a tumor tissue microarray from 123 women whose breast cancer began between ages 25 and 49, all of whom advanced to invasive disease. Of these, 56 percent lacked DEAR1 expression in their tumors, which was associated with 58 percent local recurrence-free survival 15 years after surgery. For those with DEAR1 expression, local recurrence-free survival was 95 percent at 15 years.

"Immunohistochemical staining for DEAR1 could potentially be performed in any hospital setting, and such an assay might predict which women are at a high risk of recurrence and potentially help guide treatment decisions" Killary said, noting the results will need to be validated in a larger cohort of patients.

Breast cancer that develops before age 50 tends to be more aggressive and more likely to recur even in the absence of invasion of the lymph nodes at diagnosis. "Approximately one-fourth of women without nodal involvement will experience a
'/>"/>

Contact: Scott Merville
smerville@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Novel gene predicts local recurrence in early-onset breast cancer
2. Positive Results for Ophthotechs Novel Therapy for Wet AMD - Study of Anti-PDGF and Anti-VEGF Therapy Shows Significant Neovascular Regression and Enhanced Visual Outcome
3. Fixed Dosed Combination Agents and Novel Antihypertensives Are Expected to Face Tougher Formulary Restrictions
4. Compendia Bioscience Announces Collaboration with MDS Pharma Services to Deliver Novel Solution for Oncology Drug Development
5. Spiritual Leaders Teachings Collected in New Novel
6. Novel role of protein in generating amyloid-beta peptide
7. Novel cancer drug reduces neuroblastoma growth by 75 percent
8. Porter Novelli Begins Work With NHLBI on COPD Awareness Effort
9. Ethicon Endo-Surgery Novel Investigational Notes and SSL Devices Featured in 15 Presentations at Sages
10. Singapore First in Southeast Asia to Use Novel Treatment for Sports and Musculoskeletal Injuries
11. Mount Sinai researchers discover novel mechanisms that might causally link type-2 diabetes to Alzheimers disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Novel gene predicts local recurrence in early onset breast cancer
(Date:7/31/2015)... Jacksonville, FL (PRWEB) , ... July 31, 2015 ... ... has announced an important workshop at its new True North Conference Center. The ... attend so that the Jacksonville community may be more aligned in the effort ...
(Date:7/31/2015)... Washington, PA (PRWEB) , ... July 31, 2015 , ... ... specialties, is excited to launch three new Board Exam Courses. , The additions ... Smartest Doc Board Exam Prep from MDLinx makes preparing for the exam easy and ...
(Date:7/31/2015)... ... July 31, 2015 , ... According to an article published July ... they could reach a consensus on the steps that need to be taken to ... reached 90 percent consensus on a series of steps that each surgeon must complete ...
(Date:7/31/2015)... ... July 31, 2015 , ... Cosmetic Town has ... alike on various plastic surgery procedures including, but not limited to, abdominoplasty, blepharoplasty, ... procedures like Botox and fillers. , Staying up to date with the ...
(Date:7/31/2015)... ... July 31, 2015 , ... Transfinder, a software company based in Schenectady, ... up 16 percent year-over-year for the first six months ended June 30, 2015 compared ... Transfinder to beat last year’s record-revenue mark of $10.4 million. , “We know what ...
Breaking Medicine News(10 mins):Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 3Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 2Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 3Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 2Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 3Health News:Cosmetic Town: Now Providing Interactive And Vital Medical Knowledge 2Health News:Transfinder Closes First Half of 2015 with Record Revenue 2
... Assisted Living At Home ... extensive ratings and reviews. Finding a quality retirement community ... resources out there dedicated to assisting families to make the right ... information is compounded by the fact that most people do not ...
... plans offer lower premiums, greater peace of mind , ... the region are finding themselves in a serious predicament: less ... jobs have received employment offers, according to the National Association ... health insurance. , , As a result, many ...
... repair damaged cardiac muscle, surgeons say , TUESDAY, June 30 ... procedure in which a patient received injections of his own ... 39-year-old man is the first of 16 people who will ... trial being conducted at Cedars-Sinai Heart Institute in Los Angeles. ...
... concern is that the drug can cause liver damage, even ... -- U.S. health advisers recommended Tuesday to lower the maximum ... Excedrin and many other pain-killing medications. , The advisers, vote ... report last month. It found that severe liver damage and ...
... women , TUESDAY, June 30 (HealthDay News) -- ... components of metabolic syndrome might be at increased risk ... Metabolic syndrome, also known as insulin resistance syndrome, consists ... high blood glucose levels, impaired glucose tolerance, abnormal lipid ...
... With his legacy in the balance, Governor urged to sign ... With just 12 hours left until California begins to default ... small businesses, health care workers and community activists are gathering ... that Governor Schwarzenegger stop blocking a compromise budget package that ...
Cached Medicine News:Health News:New Assisted Living at Home (assistedlivingathome.com) Database Locates Ideal Retirement Communities for Your Loved One 2Health News:Graduates Needing Health Insurance Have Cost-Effective Options 2Health News:Graduates Needing Health Insurance Have Cost-Effective Options 3Health News:U.S. Doctors Treat Heart Attack With Man's Own Stem Cells 2Health News:FDA Advisers Urge Smaller Doses of Acetaminophen 2Health News:FDA Advisers Urge Smaller Doses of Acetaminophen 3Health News:Metabolic Syndrome May Make Breast Cancer More Likely 2
(Date:7/31/2015)... -- More than 1,500 substance abuse prevention and treatment ... Indianapolis Aug. 2-6 for Community Anti-Drug ... . The week-long training, held at the JW Marriott, ... nation,s biggest public health challenges – youth drug use. ... one-of-a-kind intensive training opportunity, offering more than 70 half-day ...
(Date:7/31/2015)... , July 31, 2015  Boston Children,s Hospital ... from 3D printing of their anatomy before undergoing ... cerebrovascular malformations (abnormalities in the brain,s blood vessels) ... online today in the Journal of Neurosurgery: ... 3D printing and synthetic resins to create custom, ...
(Date:7/31/2015)... Pa. , July 31, 2015 ... fully integrated specialty pharmaceutical company focused on developing, ... the closing of its previously announced underwritten public ... at a public offering price of $11.25 per ... offering included 1,000,000 shares issued upon the exercise ...
Breaking Medicine Technology:Community Leaders From Across The Country Head To Indianapolis For CADCA 2015 Mid-Year Training Institute Aug. 2-6 23D Printing Helps Doctors Rehearse Complex Brain Procedures 23D Printing Helps Doctors Rehearse Complex Brain Procedures 33D Printing Helps Doctors Rehearse Complex Brain Procedures 4Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 2Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 4
... Ga., April 16, 2012  GeckoSystems Intl. Corp. (Pink ... ) -- is closely reviewing the scope and ... wheelchair technology. As a result of recent enhancements ... suite of fundamental mobile robot solutions for automatic, ...
... 16, 2012  Morphotek®, Inc., a subsidiary of Eisai Inc., ... II study evaluating the safety and efficacy of MORAb-004 ... refractory to all standard therapy. MORAb-004 is a monoclonal ... The trial is a randomized, double-blind, ...
Cached Medicine Technology:GeckoSystems Evaluates Europe's Robotic Wheelchair Market 2GeckoSystems Evaluates Europe's Robotic Wheelchair Market 3GeckoSystems Evaluates Europe's Robotic Wheelchair Market 4GeckoSystems Evaluates Europe's Robotic Wheelchair Market 5GeckoSystems Evaluates Europe's Robotic Wheelchair Market 6Morphotek®, Inc. Announces Initiation of MORAb-004 Phase 2 Study in Metastatic Colorectal Cancer 2Morphotek®, Inc. Announces Initiation of MORAb-004 Phase 2 Study in Metastatic Colorectal Cancer 3
The K-ASSAY ITA Lyophilized Multi-Control Set is intended to be used as a consistent test sample of known concentration for monitoring the performance of K-ASSAY immunoturbidimetric assays for the li...
... K-ASSAY ASO / RF / ... to be used as a ... concentration for monitoring the performance ... Rheumatoid Factor (RF), and C-Reactive ...
... The Directigen EZ Flu A+B test ... direct and qualitative detection of influenza A ... and throat swabs of symptomatic patients. The ... differentiated test, such that influenza A viral ...
... The InVance Male Sling System is an ... mild to moderate stress urinary incontinence in ... solution for men who are not candidates ... limited manual dexterity, limited mental capacity or ...
Medicine Products: